Danaher Corp (NYSE:DHR)
| 287.17 Delayed Data As of Jan 19 |  +0.14 / +0.05%Today’s Change | 211.22 Today|||52-Week Range 333.96 | -12.72% Year-to-Date |
Latest DHR News | Press Releases
Today’s Trading
| Previous close | 287.03 |
| Today’s open | 289.50 |
| Day’s range | 286.94 - 293.31 |
| Volume | 772 |
| Average volume (3 months) | 2,566,941 |
| Market cap | $209.6B |
Data as of 4:02pm ET, 01/19/2022
Growth & Valuation
| Earnings growth (last year) | +42.79% |
| Earnings growth (this year) | +56.04% |
| Earnings growth (next 5 years) | +23.22% |
| Revenue growth (last year) | +24.41% |
| P/E ratio | 36.9 |
| Price/Sales | 7.16 |
| Price/Book | 5.71 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| TMOThermo Fisher Scient... | +3.27 | +0.55% |
| AAgilent Technologies... | +0.03 | +0.02% |
| MTDMettler-Toledo Inter... | +1.10 | +0.07% |
| PKIPerkinElmer Inc | +0.07 | +0.04% |
Data as of 4:00pm ET, 01/19/2022
Financials
| Next reporting date | January 27, 2022 |
| EPS forecast (this quarter) | $2.53 |
| Annual revenue (last year) | $22.3B |
| Annual profit (last year) | $3.6B |
| Net profit margin | 16.36% |
Profile
Sector Health Technology |
Industry Medical Specialties |
No executives to display |
Corporate headquarters Washington, District Of Columbia |
Forecasts
